Annovis Bio, Inc. (ANVS) Total liabilities 2019–2025
Annovis Bio, Inc. (ANVS) total liabilities at each fiscal year-end, per SEC filings.
$4.2MFY2025 · since FY2019: $2.6M → $4.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.2M | -8.4% |
| FY2024 | $4.6M | -74.3% |
| FY2023 | $18.0M | +133.3% |
| FY2022 | $7.7M | +411.0% |
| FY2021 | $1.5M | +160.5% |
| FY2020 | $578,380 | -77.9% |
| FY2019 | $2.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice